소아청소년의 결핵 감염과 질병에 대한 최신 지견
Update on Tuberculosis in children and adolescents
4
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Tuberculosis is a disease with high morbidity and mortality in children worldwide. Despite significant improvements in diagnostic methods, scientific researches and clinical trials for new regimens of treatment or prevention in adult tuberculosis, childhood tuberculosis has been relatively neglected. Children are at high risk of severe disease, and reactivation of latent infection in adulthood perpetuates the epidemic. Therefore, a policy of tuberculosis control in childhood should be emphasized to improve control in the total population. To understand the new view of childhood tuberculosis, this article describes changes in the disease's national epidemiology, new diagnostic tools and treatment strategies, and multi-drug resistance.
Abstract
Tuberculosis is a disease with high morbidity and mortality in children worldwide. Despite significant improvements in diagnostic methods, scientific researches and clinical trials for new regimens of treatment or prevention in adult tuberculosis, childhood tuberculosis has been relatively neglected. Children are at high risk of severe disease, and reactivation of latent infection in adulthood perpetuates the epidemic. Therefore, a policy of tuberculosis control in childhood should be emphasized to improve control in the total population. To understand the new view of childhood tuberculosis, this article describes changes in the disease's national epidemiology, new diagnostic tools and treatment strategies, and multi-drug resistance.
참고문헌 (34)
- Brent AJ, "Childhood tuberculosis: out of sight, out of mind?", Trans R Soc Trop Med Hyg, 102, pp.217~218 (2008)
- Marais BJ, "Childhood pulmonary tuberculosis: old wisdom and new challenges", Am J Respir Crit Care Med, 173, pp.1078~1090 (2006)
- Centers for Disease Control and Prevention, "Targeted tuberculin testing and treatment of latent tuberculosis infection", MMWR, 49(RR-6), pp.1~51 (2000)
- Starke JR, "New concepts in childhood tuberculosis", Curr Opin Pediatr, 19, pp.306~313 (2007)
- WHO Report 2007: Global Tuberculosis Control (Surveillance, Planning, Financing), "World Health Organization", WHO, ~ (2007)
- Korea Centers for Disease Control and Prevention, "Elimination of TB 2030" (2008), Korea Centers for Disease Control and Prevention
- Korea Centers for Disease Control and Prevention, "Korean Institute of Tuberculosis. Annual Report on the Tuberculosis Cases Notified in Korea, 2005" (2006), Korea Centers for Disease Control and Prevention
- Kim JH, "Evaluation for the usefulness of BCG vaccine: a survey for prevalence change of disseminated tuberculosis in children", pp.42~46 (2007), Korea Food and Drug Administration
- "Stop TB Partnership Childhood Tuberculosis Subgroup. Chapter 1: introduction and diagnosis of tuberculosis in children", Int J Tuberc Lung Dis, 10, pp.1091~1097 (2006)
- Zar HJ, "Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study", Lancet, 365, pp.130~134 (2005)
- Hoskyns W, "Paediatric tuberculosis", Postgrad Med J, 79, pp.272~278 (2003)
- Farhat M, "False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?", Int J Tuberc Lung Dis, 10, pp.1192~1204 (2006)
- National Institute for Health and Clinical Excellence, "Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control", pp.105~116 (2006), Royal College of Physicians
- Centers for Disease Control and Prevention, "Guidelines for using the QuantiFERONⓇ-TB Gold Test for detecting Mycobacterium tuberculosis infection, United States", MMWR, 54(RR-15), pp.49~55 (2005)
- Menzies D, "Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research", Ann Intern Med, 146, pp.340~354 (2007)
- Davies PDO, "The use of interferon-γ- based blood tests for the detection of latent tuberculosis infection", Eur Respir J, 28, pp.1~3 (2006)
- Nolan CM, "Tuberculosis in a cohort of Southeast Asian Refugees. A five-year surveillance study", Am Rev Respir Dis, 137, pp.805~809 (1988)
- Pai M, "New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis", Expert Rev Mol Diagn, 6, pp.413~422 (2006)
- Machado A Jr, "Analysis of discordance between the tuberculin skin test and the interferongamma release assay", Int J Tuberc Lung Dis, 13, pp.446~453 (2009)
- O’Neal S, "Discordant tuberculin skin and interferon-gamma tests during contact investigations: a dilemma for tuberculosis controllers", Int J Tuberc Lung Dis, 13, pp.662~664 (2009)
- Marais BJ, "The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era", Int J Tuberc Lung Dis, 8, pp.392~402 (2004)
- Marais BJ, "A proposed radiological classification of childhood intra-thoracic tuberculosis", Pediatr Radiol, 34, pp.886~894 (2004)
- Marais BJ, "Radiographic signs and symptoms in children treated for tuberculosis: possible implications for symptom-based screening in resource-limited settings", Pediatr Infect Dis J, 25, pp.237~240 (2006)
- Stop TB Partnership Childhood TB Subgroup, "Guidance for national tuberculosis programmes on the management of tuberculosis in children. Chapter 2: anti-tuberculosis treatment in children", Int J Tuberc Lung Dis, 10, pp.1205~1211 (2006)
- Donald PR, "Ethambutol dosage for the treatment of children: literature review and recommendations", Int J Tuberc Lung Dis, 10, pp.1318~1330 (2006)
- Schaaf HS, "Isoniazid pharmacokinetics in children treated for respiratory tuberculosis", Arch Dis Child, 90, pp.614~618 (2005)
- Guidelines for the programmatic management of drug-resistant tuberculosis, "World Health Organization", WHO, 135~139 (2008)
- Bai GH, "Trend of anti-tuberculosis drug resistance in Korea, 1994-2004", Int J Tuberc Lung Dis, 11, pp.571~576 (2007)
- Kim HR, "Impact of extensive drug resistance on treatment outcomes in non–HIV-infected patients with multidrug- resistant tuberculosis", Clin Infect Dis, 45, pp.1290~1295 (2007)
- Kwon YS, "Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drugresistant tuberculosis", Clin Infect Dis, 47, pp.496~502 (2008)
- Stevens JP, "Chemoprophylaxis of multidrugresistant tuberculous infection in HIV-uninfected individuals using ciprofloxacin and pyrazinamide: a decision analysis", Chest, 108, pp.712~717 (1995)
- Horn DL, "Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis", N Engl J Med, 330, pp.1241~ (1994)
- Schaaf HS, "Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up", Pediatrics, 109, pp.765~771 (2002)
- American Thoracic Society, "Targeted tuberculin testing and treatment of latent tuberculosis infection", Am J Respir Crit Care Med, 161, pp.221~247 (2000)
